BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33816305)

  • 21. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
    Luo JF; Xu J; Zheng JZ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC-dependent MiR-7-5p regulated apoptosis and autophagy in diffuse large B cell lymphoma by targeting AMBRA1.
    Zhang C; Wang K; Tao J; Zheng C; Zhai L
    Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38393538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA
    Chen X; Zhao S; Li Q; Xu C; Yu Y; Ge H
    Front Genet; 2020; 11():574145. PubMed ID: 33281873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hsa-MicroRNA-28-5p Inhibits Diffuse Large B-Cell Lymphoma Cell Proliferation by Downregulating 14-3-3
    Yan S; Chen Y; Yang M; Zhang Q; Ma J; Liu B; Yang L; Li X
    Evid Based Complement Alternat Med; 2022; 2022():4605329. PubMed ID: 35027933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
    Huang Y; Lin Y; Song X; Wu D
    Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA SNHG5 can Regulate the Proliferation and Migration of Diffuse Large B Cell Lymphoma Progression via Targeting miR-181-5p/XIAP.
    Xing X; Xu T; Liu B; Guo Q
    J Cancer; 2022; 13(3):784-792. PubMed ID: 35154447
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA-383-5p predicts favorable prognosis and inhibits the progression of diffuse large B-cell lymphoma.
    Chen LY; Han BQ; Zhang XM; Yu XB; Yao DD; Yu LQ
    Oncol Lett; 2021 Jul; 22(1):515. PubMed ID: 33986875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway.
    Guo X; Zhang J; Zeng J; Guo Y; Zhao L
    PeerJ; 2023; 11():e16388. PubMed ID: 37953776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1/miR-182-5p/BCL-2 regulatory axis in diffuse large B-cell lymphoma.
    Yang Q; Lu Y; Du A
    J Cell Mol Med; 2024 Jan; 28(2):e18046. PubMed ID: 38037859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of SNHG15 facilitates cell proliferation, migration, invasion and suppresses cell apoptosis in breast cancer by regulating miR-411-5p/VASP axis.
    Liu LB; Jiang ZJ; Jiang XL; Wang S
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1899-1912. PubMed ID: 32141559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis.
    Chu M; Fan Y; Wu L; Ma X; Sao J; Yao Y; Zhuang W; Zhang C
    Immun Ageing; 2022 Jan; 19(1):3. PubMed ID: 34980181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3 Pathway.
    Sun SW; Chen Y; Liao HJ; Zhang W; Xu WM; He GQ
    Evid Based Complement Alternat Med; 2022; 2022():9100056. PubMed ID: 35783530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152.
    Yang CH; Zhang XY; Zhou LN; Wan Y; Song LL; Gu WL; Liu R; Ma YN; Meng HR; Tian YL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1629-1637. PubMed ID: 29630089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
    Li FZ; Zang WQ
    World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis.
    Xu X; Xie Q; Xie M; Zeng Y; Liu Q
    Cancer Manag Res; 2021; 13():3017-3028. PubMed ID: 33854372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
    Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis.
    Chi J; Liu T; Shi C; Luo H; Wu Z; Xiong B; Liu S; Zeng Y
    Biomed Pharmacother; 2019 Oct; 118():109201. PubMed ID: 31545227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway.
    Yu X; Liu X; Wang R; Wang L
    Biochem Biophys Res Commun; 2019 May; 512(4):825-831. PubMed ID: 30928097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.